We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
+19.87%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$518M
AUM Growth
+$62M
Cap. Flow
-$4.93M
Cap. Flow %
-0.95%
Top 10 Hldgs %
88.79%
Holding
21
New
1
Increased
6
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
TTAN
ServiceTitan Inc
TTAN
+$8.78M
2
TOST icon
Toast
TOST
+$5.23M
3
KVYO icon
Klaviyo
KVYO
+$3.77M
4
IKT icon
Inhibikase Therapeutics
IKT
+$3.29M
5
CPNG icon
Coupang
CPNG
+$2.15M

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$7.66M
2
TARS icon
Tarsus Pharmaceuticals
TARS
+$6.35M
3
DDOG icon
Datadog
DDOG
+$5.2M
4
IOT icon
Samsara
IOT
+$5.14M
5
NU icon
Nu Holdings
NU
+$5.05M

Sector Composition

Rank Sector Weight
1 Technology 35.13%
2 Healthcare 34.58%
3 Financials 22.15%
4 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVYO icon
1
Klaviyo
KVYO
$5.26B
$119M 22.86%
3,649,678
+134,613
+4% +$3.77M
NU icon
2
Nu Holdings
NU
$73.6B
$115M 22.15%
6,861,399
-314,035
-4% -$5.05M
BBNX
3
Beta Bionics
BBNX
$790M
$109M 20.98%
3,570,113
– –
IKT icon
4
Inhibikase Therapeutics
IKT
$336M
$26.7M 5.15%
13,018,965
+2,068,965
+19% +$3.29M
DASH icon
5
DoorDash
DASH
$94B
$21.7M 4.18%
95,618
+5,476
+6% +$1.28M
CPNG icon
6
Coupang
CPNG
$29B
$20.5M 3.96%
870,424
+75,418
+9% +$2.15M
IOT icon
7
Samsara
IOT
$23.2B
$16.5M 3.19%
466,190
-132,724
-22% -$5.14M
DDOG icon
8
Datadog
DDOG
$91.7B
$11.7M 2.25%
85,793
-32,914
-28% -$5.2M
TOST icon
9
Toast
TOST
$20.1B
$10.7M 2.07%
301,647
+145,043
+93% +$5.23M
BIOA
10
BioAge Labs
BIOA
$487M
$10.4M 2.01%
786,353
– –
MNDY icon
11
monday.com
MNDY
$3.7B
$10M 1.93%
67,868
+9,532
+16% +$1.61M
TTAN
12
ServiceTitan Inc
TTAN
$8.62B
$9.57M 1.85%
+89,856
New +$8.78M
TXG icon
13
10x Genomics
TXG
$7.31B
$7.86M 1.52%
481,770
– –
ABOS icon
14
Acumen Pharmaceuticals
ABOS
$193M
$7.21M 1.39%
3,417,075
– –
TARS icon
15
Tarsus Pharmaceuticals
TARS
$3.04B
$6.96M 1.34%
85,000
-85,000
-50% -$6.35M
ACRV icon
16
Acrivon Therapeutics
ACRV
$83.6M
$5.12M 0.99%
2,122,605
– –
SNOW icon
17
Snowflake
SNOW
$114B
$4.44M 0.86%
20,253
-6,752
-25% -$1.65M
TSHA icon
18
Taysha Gene Therapies
TSHA
$1.94B
$3.99M 0.77%
724,873
– –
CADL icon
19
Candel Therapeutics
CADL
$897M
$2.29M 0.44%
405,837
– –
FIG
20
Figma
FIG
$13.5B
$683K 0.13%
18,286
– –
CRWD icon
21
CrowdStrike
CRWD
$221B
– –
-62,460
Closed -$7.66M

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q4 2025 Portfolio in Review

As of Q4 2025, Sands Capital Ventures held 21 positions worth $518M, up 14% from $456M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Sands Capital Ventures's Q4 2025 filing shows 1 new, 6 increased, 5 reduced and 1 closed positions. Its largest new stake was ServiceTitan Inc: 89,856 shares worth $9.57M. The largest sale was CrowdStrike, an estimated $7.66M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Sands Capital Ventures's largest Q4 2025 buy was ServiceTitan Inc: 89,856 shares worth $9.57M.
  • Sands Capital Ventures added most to Toast in Q4 2025, an estimated $5.23M increase.
  • Sands Capital Ventures's biggest Q4 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $6.35M.
  • Sands Capital Ventures fully exited CrowdStrike in Q4 2025, selling an estimated $7.66M.
  • Sands Capital Ventures's ten largest holdings make up 89% of its $518M portfolio in Q4 2025.
  • Sands Capital Ventures opened 1 new position and closed 1 in Q4 2025.
  • Sands Capital Ventures's portfolio value rose 14% quarter-over-quarter to $518M.

Based on Sands Capital Ventures's 13F filing for Q4 2025, filed 13 Feb 2026.